Skip to content

Evaluation of transversus abdominis plane block in bariatric surgery: a single center retrospective study

Evaluation of transversus abdominis plane block in bariatric surgery: a single center retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105173
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Conventional general anesthesia group
General anesthesia sufentanil group
General anesthesia TAP block/dexmedetomidine group:None

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Type of surgery: elective laparoscopic sleeve gastrectomy 2. Clear anesthesia regimen: The intraoperative anesthetic regimen (such as general anesthesia, composite nerve block, intravenous anesthesia, etc.) and postoperative analgesic strategies (such as opioids, non-steroidal anti-inflammatory drugs, regional block, etc.) are completely recorded in the medical record. 3. Data integrity: The blood pressure, heart rate, oxygen saturation, postoperative sedation/analgesia score (such as VAS, Ramsay score), blood gas index (such as PaO2, PaCO2, pH), and complications of the patient were complete during the operation. 4. Time frame: 200 patients who underwent laparoscopic sleeve gastrectomy from August 2022 to October 2023 5. Age range: The subjects of the study were aged 18-50 years 6. BMI range: 28kg/m^2<=BMI<=50kg/m^2 Patients who underwent surgery in our hospital

Exclusion criteria

Exclusion criteria: 1. Combined with other surgeries: patients who have undergone other abdominal surgeries (such as cholecystectomy, hernia repair) at the same time. 2. Lack of anesthesia or analgesic data: those with incomplete records of anesthesia protocol, postoperative analgesic drug use or effect evaluation in medical records. 3. Interference with underlying diseases: those with severe cardiopulmonary diseases (such as COPD, heart failure), liver and kidney insufficiency (Child-PughC or eGFR<30), coagulation dysfunction or psychiatric diseases that may affect the postoperative evaluation. 4. Emergency surgery or laparotomy: patients who need to be transferred to laparotomy or emergency surgery due to bleeding, adhesions, etc. 5. Postoperative transfer to ICU: Those who need to be directly transferred to ICU due to their condition after surgery, resulting in interference with sedation/analgesia regimen or blood gas indicators. 6. Lost follow-up: those who were discharged from the hospital or lost to follow-up within 24 hours after surgery, and the key outcome data could not be obtained. 7. Drug allergies or contraindications: those who have a history of allergy to or contraindications to the use of anesthetic/analgesic drugs involved in the study

Design outcomes

Primary

MeasureTime frame
Numerical rating scale and sufentanil consumption;

Secondary

MeasureTime frame
The sedation score;The incidence of postoperative nausea and vomiting;The length of stay in the PACU;Length of hospitalization;

Countries

China

Contacts

Public ContactZhou Ting

The First Affiliated Hospital of Jinan University

tina510623@foxmail.com+86 20 3868 8779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026